Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adil Maarouf

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
La Revue Du Praticien|May 31, 2022
[Current management of multiple sclerosis]Adil Maarouf, Bertrand Audoin, Jean Pelletier
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 24, 2020
Maintenance of natalizumab during the first trimester of pregnancy in active multiple sclerosisSarah Demortiere, Audrey Rico, Adil Maarouf, et al.
Medical Image Analysis|April 14, 2015
Diffusion MRI abnormalities detection with orientation distribution functions: a multiple sclerosis longitudinal studyOlivier Commowick, Adil Maarouf, Jean-Christophe Ferré, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 27, 2020
Extending rituximab dosing intervals in patients with MS during the COVID-19 pandemic and beyond?Adil Maarouf, Audrey Rico, Clemence Boutiere, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 7, 2023
Disease Evolution in Women With Highly Active MS Who Suspended Natalizumab During Pregnancy vs Rituximab/Ocrelizumab Before ConceptionSarah Demortiere, Adil Maarouf, Audrey Rico, et al.
Journal of Translational Medicine|February 22, 2019
High levels of serum soluble TWEAK are associated with neuroinflammation during multiple sclerosisAdil Maarouf, Delphine Stephan, Marie-Pierre Ranjeva, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 16, 2021
Rituximab-Induced Hypogammaglobulinemia and Infections in AQP4 and MOG Antibody-Associated DiseasesAlexandre Avouac, Adil Maarouf, Jan-Patrick Stellmann, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 24, 2021
Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With RituximabMarine Perriguey, Adil Maarouf, Jan-Patrick Stellmann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 18, 2020
Comparison of rituximab originator (MabThera<sup>®</sup>) to biosimilar (Truxima<sup>®</sup>) in patients with multiple sclerosisThomas Perez, Audrey Rico, Clémence Boutière, et al.
Plos One|January 22, 2025
In vivo mapping of sodium homeostasis disturbances in individual ALS patients: A brain 23Na MRI studyAude-Marie Grapperon, Mohamed Mounir El Mendili, Adil Maarouf, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
La Revue Du Praticien|May 31, 2022
[Current management of multiple sclerosis]Adil Maarouf, Bertrand Audoin, Jean Pelletier
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 24, 2020
Maintenance of natalizumab during the first trimester of pregnancy in active multiple sclerosisSarah Demortiere, Audrey Rico, Adil Maarouf, et al.
Medical Image Analysis|April 14, 2015
Diffusion MRI abnormalities detection with orientation distribution functions: a multiple sclerosis longitudinal studyOlivier Commowick, Adil Maarouf, Jean-Christophe Ferré, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 27, 2020
Extending rituximab dosing intervals in patients with MS during the COVID-19 pandemic and beyond?Adil Maarouf, Audrey Rico, Clemence Boutiere, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 7, 2023
Disease Evolution in Women With Highly Active MS Who Suspended Natalizumab During Pregnancy vs Rituximab/Ocrelizumab Before ConceptionSarah Demortiere, Adil Maarouf, Audrey Rico, et al.
Journal of Translational Medicine|February 22, 2019
High levels of serum soluble TWEAK are associated with neuroinflammation during multiple sclerosisAdil Maarouf, Delphine Stephan, Marie-Pierre Ranjeva, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 16, 2021
Rituximab-Induced Hypogammaglobulinemia and Infections in AQP4 and MOG Antibody-Associated DiseasesAlexandre Avouac, Adil Maarouf, Jan-Patrick Stellmann, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 24, 2021
Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With RituximabMarine Perriguey, Adil Maarouf, Jan-Patrick Stellmann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 18, 2020
Comparison of rituximab originator (MabThera<sup>®</sup>) to biosimilar (Truxima<sup>®</sup>) in patients with multiple sclerosisThomas Perez, Audrey Rico, Clémence Boutière, et al.
Plos One|January 22, 2025
In vivo mapping of sodium homeostasis disturbances in individual ALS patients: A brain 23Na MRI studyAude-Marie Grapperon, Mohamed Mounir El Mendili, Adil Maarouf, et al.
Pageof 6